Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases
TJ Barrett, ME Potter, IK Wachsmuth - The Journal of infectious diseases, 1989 - JSTOR
TJ Barrett, ME Potter, IK Wachsmuth
The Journal of infectious diseases, 1989•JSTORContinuous Peritoneal Infusion of Shiga-like Toxin II (SLT II) as a Model for SLT II-Induced
Diseases Page 1 THE JOURNAL OF INFECTIOUS DISEASES * VOL. 159, NO. 4 * APRIL 1989
This article is in the public domain. 0022-1899/89/5904-0028 Continuous Peritoneal Infusion
of Shiga-like Toxin II (SLT II) as a Model for SLT II-Induced Diseases Strains of Escherichia
coli that produce moderate to high levels of Shiga-like toxins have been epidemiologically
incriminated in the pathogenesis of hemorrhagic colitis (HC), hemolytic uremic syndrome …
Diseases Page 1 THE JOURNAL OF INFECTIOUS DISEASES * VOL. 159, NO. 4 * APRIL 1989
This article is in the public domain. 0022-1899/89/5904-0028 Continuous Peritoneal Infusion
of Shiga-like Toxin II (SLT II) as a Model for SLT II-Induced Diseases Strains of Escherichia
coli that produce moderate to high levels of Shiga-like toxins have been epidemiologically
incriminated in the pathogenesis of hemorrhagic colitis (HC), hemolytic uremic syndrome …
Materials and Methods
SLT I preparation. SLT II was purified from E. coli strain NM522 containing the recombinant plasmid pEBI as previously described [11]. Endotoxin contamination was
JSTOR